Torii Pharmaceutical Co., Ltd. (4551.T)
JPY 4440.0
(0.57%)
JPY 4440.0
(0.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 54.63 Billion | 48.89 Billion | 46.98 Billion | 41.69 Billion | 42.99 Billion | 62.55 Billion |
| Cost of Revenue | 29.84 Billion | 25.51 Billion | 22.64 Billion | 19.96 Billion | 20.7 Billion | 31.84 Billion |
| Gross Profit | 24.79 Billion | 23.37 Billion | 24.33 Billion | 21.73 Billion | 22.29 Billion | 30.7 Billion |
| Operating Expenses | 19.53 Billion | 17.83 Billion | 19.67 Billion | 16.99 Billion | 20.86 Billion | 25.75 Billion |
| Selling, General and Administrative Expenses | 16.04 Billion | 1.58 Billion | 4.18 Billion | 3.31 Billion | 2.83 Billion | 5.17 Billion |
| Research and Development Expenses | 3.49 Billion | 1.66 Billion | 832 Million | 596 Million | 2.95 Billion | 4.13 Billion |
| Other Expenses | - | 14.59 Billion | 14.66 Billion | 13.08 Billion | 15.07 Billion | 24 Million |
| Cost and Expenses | 49.6 Billion | 43.35 Billion | 42.32 Billion | 36.95 Billion | 41.56 Billion | 57.59 Billion |
| Operating Income | 5.03 Billion | 5.54 Billion | 4.65 Billion | 4.73 Billion | 1.43 Billion | 4.95 Billion |
| Interest Expense | - | - | - | - | - | 2.04 Billion |
| Income Tax Expense | 1.47 Billion | 1.77 Billion | 1.39 Billion | 729 Million | 10.33 Billion | 1.86 Billion |
| Earnings before Tax | 5.59 Billion | 5.72 Billion | 4.76 Billion | 4.22 Billion | 37.7 Billion | 3.03 Billion |
| Net Income | 4.11 Billion | 3.94 Billion | 3.37 Billion | 3.49 Billion | 27.36 Billion | 1.16 Billion |
| Earnings Per Share Basic | 146.57 | 140.38 | 120.11 | 124.47 | 974.99 | 41.49 |
| Earnings Per Share Diluted | 146.57 | 140.38 | 120.11 | 124.46 | 974.99 | 41.49 |
| Weighted Average Shares Outstanding | 28.1 Million | 28.09 Million | 28.09 Million | 28.07 Million | 28.06 Million | 28.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.1 Million | 28.09 Million | 28.09 Million | 28.08 Million | 28.06 Million | 28.05 Million |
| Gross Margin | 0.45 | 0.48 | 0.52 | 0.52 | 0.52 | 0.49 |
| EBIT Margin | 0.10 | 0.12 | 0.11 | 0.13 | 0.06 | 0.10 |
| Profit Margin | 0.08 | 0.08 | 0.07 | 0.08 | 0.64 | 0.02 |
| EBITDA | 5.27 Billion | 5.97 Billion | 5.04 Billion | 4.68 Billion | 38.5 Billion | 3.87 Billion |
| Earnings Before Tax Margin | 0.09 | 0.11 | 0.10 | 0.11 | 0.03 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 15.02 Billion | 14.85 Billion | 13.45 Billion | 54.63 Billion | 15.5 Billion | 13.43 Billion |
| Cost of Revenue | 8.23 Billion | 8.21 Billion | 7.48 Billion | 30.06 Billion | 8.74 Billion | 7.32 Billion |
| Gross Profit | 6.79 Billion | 6.64 Billion | 5.96 Billion | 24.57 Billion | 6.75 Billion | 6.1 Billion |
| Operating Expenses | 5.27 Billion | 4.88 Billion | 4.58 Billion | 19.53 Billion | 4.93 Billion | 4.4 Billion |
| Selling, General and Administrative Expenses | 4.44 Billion | 4.05 Billion | 4.04 Billion | - | 4.25 Billion | 388 Million |
| Research and Development Expenses | 833 Million | 831 Million | 532 Million | - | 679 Million | 398 Million |
| Other Expenses | - | 5 Million | -2 Million | 20 Million | 4 Million | 5 Million |
| Cost and Expenses | 13.5 Billion | 13.1 Billion | 12.06 Billion | 49.6 Billion | 13.68 Billion | 11.73 Billion |
| Operating Income | 1.51 Billion | 1.75 Billion | 1.38 Billion | 5.03 Billion | 1.82 Billion | 1.7 Billion |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 388 Million | 474 Million | 281 Million | 1.47 Billion | 529 Million | 491 Million |
| Earnings before Tax | 1.69 Billion | 1.81 Billion | 1.16 Billion | 5.59 Billion | 2.28 Billion | 1.77 Billion |
| Net Income | 1.3 Billion | 1.34 Billion | 878 Million | 4.11 Billion | 1.75 Billion | 1.28 Billion |
| Earnings Per Share Basic | 46.39 | 47.78 | 31.24 | - | 62.30 | 45.61 |
| Earnings Per Share Diluted | 46.39 | 47.78 | 31.24 | - | 62.30 | 45.61 |
| Weighted Average Shares Outstanding | 28.11 Million | 28.1 Million | 28.1 Million | 28.1 Million | 28.1 Million | 28.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.11 Million | 28.1 Million | 28.1 Million | 28.1 Million | 28.1 Million | 28.1 Million |
| Gross Margin | 0.45 | 0.45 | 0.44 | 0.45 | 0.44 | 0.45 |
| EBIT Margin | 0.12 | 0.12 | 0.11 | - | 0.13 | 0.13 |
| Profit Margin | 0.09 | 0.09 | 0.07 | 0.08 | 0.11 | 0.10 |
| EBITDA | 1.79 Billion | 1.85 Billion | 1.49 Billion | - | 1.94 Billion | 1.78 Billion |
| Earnings Before Tax Margin | 0.10 | 0.12 | 0.10 | 0.09 | 0.12 | 0.13 |
GANESHHOUC
9989
8051
BLUEDART
3682
SNIM